NEW YORK (GenomeWeb) – South Korea's Seegene has announced a joint venture in Mexico with Biodist Group to bring its PCR-based molecular diagnostics to the Latin American region.

Under the terms of the agreement, Seegene and Biodist will each hold a 50 percent stake in Biodist-Seegene Diagnostics. Seegene will license proprietary molecular diagnostics technologies and development expertise while Biodist will provide marketing and sales distribution.